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Abstract 
A two step flow-through chromatography process is proposed as an universal approach to purify viruses. A resin 
column with reduced surface area was developed for the first step to remove bulk of the host cell protein (HCP) from 
a viral feed stream while allowing most of the virus to flow-through. For the second step a chromatographic 
separations strategy using a primary amine membrane adsorber and multivalent ions in the mobile phase was 
developed. This enabled selective binding of host cell DNA (hcDNA) to the membrane and complete recovery of 
virus in the flow-through mode. The techniques were evaluated using cell culture grown influenza virus and 
bacteriophage feed streams. Virus recoveries of >70-80% and 100% were achieved for the column and membrane 
approaches respectively. The column cleared > 80% of the HCP and the membrane adsorber reduced whole hcDNA 
levels to <10 ng.  
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1. Introduction 
Traditionally liquid chromatography has been used in bind and elute mode which is at bare minimum a 
three step batch operation. In this approach the molecule of interest is bound to a stationary phase and the 
undesired impurities are allowed to flow through the column along with the mobile phase. The molecule 
of interest is then recovered from the stationary phase by changing fluid parameters such as conductivity, 
pH, polarity and chaotropicity. As a result this method may require significant amount of buffers, post 
processing of product and longer processing and turnaround times. Nevertheless, it is ideal for 
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concentrating the product of interest in situations where there is a large impurity level in the feed stream 
such as those found in early stage monoclonal antibody purification where typically resin based affinity or 
cation exchange chromatography is used [1, 2]. The approach minimizes the amount of stationary phase 
required by eliminating the need for binding large loads of impurity making the process more economical.  
A reverse mode of chromatographic operation called as flow-through chromatography also exists in 
which the impurities in the feed stream are bound to the stationary phase and the molecule of interest 
flows through the column along with the mobile phase. For moderate to low concentrations of impurities 
in the feed a flow-through mode of operation is most convenient as the process yields product in a 
continuous single step with optimal use of the stationary and mobile phase. This mode has been 
successfully commercialized for endotoxin and viral clearance in late stage monoclonal antibodies 
purification [3]. Typically, mammalian cell culture based viral harvests for vaccine preparation tend to 
have a moderate to low impurity level as compared to mAbs which puts them in the realm of flow-
through chromatography. 
The choice of either approach depends on variables such as buffer conditions, impurity load, capacity 
of stationary phase for product and impurity, pI of the product and impurities, stability of the target 
molecule and principle of separation. The type of stationary phase is another important consideration for 
selecting the mode of operation. For example, resins or beads have a larger internal surface area 
accessible to small bio-molecules and hence a high capacity for proteins. On the other hand membranes 
have a large accessible surface area for big bio-molecules and hence higher capacity for DNA and 
viruses. Consequently it can be expected that for flow-through removal of HCP and host cell DNA 
(hcDNA) from a feed stream, it would be ideal to use a combination of bead and membrane based 
stationary phases.  
This article describes the purification of influenza virus using the above approach. A bead based flow-
through column was developed as the first step to maximize virus recovery and HCP clearance from a 
feed harvested from mandarin darby canine kidney (MDCK) cell culture medium. As the second step a 
primary amine based membrane adsorber was used for hcDNA removal from the feed stream. The study 
demonstrates that flow-through chromatography is a viable approach for viral vaccine purification.  
2. Experimental 
2.1. Recovery of Bacteriophage φ6 
A solution of PBS (pH 7.2) containing 0.2 mg/ml bovine serum albumin (BSA) was spiked with 
bacteriophage Φ6 grown in Pseudomonas pseudoalcaligenes cells [4] to a final concentration of 5.9 x 108 
pfu/ml. 100 ml of this solution was passed through 0.5 ml columns of 90 µm and 200 µm anion exchange 
beads (AEX, SepharoseTM Fast Flow and Big Beads, GE Healthcare) and 90 µm neutral control beads 
(SepharoseTM Fast Flow, GE Healthcare) pre-equilibrated in phosphate buffer at a flow rate of 1 ml/min. 
The flow through fractions (10 ml each) were collected and the concentration of Φ6 in these were 
determined using a plaque assay. This concentration was used to plot the break-through curve and 
calculate the recovery of the virus.  
2.2. Recovery of Influenza B Virus 
Crude cell culture supernatant (20 ml) containing influenza virus type B/Lee/40 (concentration-1280 
HAU/ml) grown in MDCK cells [5] and all other impurities such as host cell protein, hcDNA and cell 
culture additives was processed through 1 ml columns of 34 µm, 90 µm and 200 µm anion exchange 
beads (SepharoseTM High Performance, Fast Flow and Big Beads, GE Healthcare) and 90 µm neutral 
control beads (SepharoseTM Fast Flow, GE Healthcare) at a flow rate of 1 ml/min.  The flow-through from 
these columns was collected in 2ml fractions and the concentration of the virus in these fractions was 
determined by hemagglutination (HA) assay [6]. 
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Figure 1: Virus binding to column decreases with increase 
in bead size due to reduction in external surface are per 
unit volume resulting in higher virus recovery. 
2.3.  Flow-Through Column Purification of Influenza A Virus 
Cell culture supernatant containing influenza virus type A/Wisconsin/N1H1 grown in MDCK cells [5] 
and other impurities was exchanged into 50 mM Tris buffer (pH 8) using a 10 KD membrane. Average 
virus titer and HCP concentration in final feed was 3840 HAU/ml and 275 µg/ml respectively. The feed 
was processed through three prototype columns containing 200 µm beads with three different chemistries 
such as, anion exchange beads (AEX), cation exchange (CEX) and hydrophobic interaction (HIC) and a 
90 µm AEX control column at a flow rate of 0.2 ml/min. The flow through fractions from these columns 
were collected and assayed for virus using HA assay and a total  protein using a colorimetric assay (HCP, 
Pierce® BCA Protein Assay Kit, Thermo Fisher Scientific) [7]. 
2.4. Flow -Through Membrane Purification of Influenza A Virus 
Influenza virus type A/Wisconsin/N1H1 grown in MDCK cells was exchanged into 50 mM Tris buffer 
and buffers containing multivalent ions such as 50mM phosphate buffer with 0.3M NaCl, 50 Tris buffer 
with 50mM phosphate and 0.3M NaCl, 50mM Tris with 50mM citrate and 0.3M NaCl respectively using 
a 10 KD Centricon centrifugal membrane filter (EMD Millipore). All the buffers used were at pH 8. The 
average virus titer and hcDNA concentration in final feed was 10,000 HAU/ml and 1-2 µg/ml 
respectively. The feed was processed through a 0.8ml ChromaSorb device containing 8 layers of primary 
amine coated membrane. The flow through fractions from these columns were collected and assayed for 
virus using HA assay and DNA using a fluorescent assay (Quant-iTTM Picogreen assay kit, Invitrogen) 
[8]. 
3. Results and Discussions 
3.1. Flow thorough column chromatography for host cell protein removal 
3.1.1. Principle 
 
Similar to proteins most viruses bind to ion-
exchange or hydrophobic resins. But the nature 
of binding of viruses to beads is limited by their 
molecular size. Because the size of viruses is 
larger than the pore size of most beads they bind 
only to the external surface area of beads, 
whereas proteins on the other hand mostly bind 
to the large internal surface area of beads. 
Consequently, it can be expected that the virus 
binding to a column packed with beads can be 
minimized by reducing the external surface area 
per unit volume in the column. One method to 
achieve this would be to increase the size of 
beads i.e. use bigger beads in the column. 
Theoretically such a change should not 
significantly affect the internal surface area per 
unit volume of the column as this is typically 
orders of magnitude greater than the external 
surface area. Hence as shown in Figure 1, using 
bigger beads in a column should decrease the 
virus binding to the column which in turn 
109 Ganesh Iyer et al. /  Procedia in Vaccinology  6 ( 2012 )  106 – 112 
should translate into improved virus recovery in a flow-through mode without significantly affecting the 
capacity of the column for HCP impurity. 
   
3.1.2. Effect of Bead Size on Virus Recovery 
 
  
Figure 2: (a) Increase in bacteriophage φ6 recovery with increase in AEX bead size. (b) Increase in Influenza B virus 
recovery with increase in AEX bead size. 
 
To evaluate the theory that reducing the surface external area per unit volume of a column by 
increasing the bead size can improve virus recovery, the effect of bead size on virus recovery in a column 
with a fixed volume was studied as described in sections 2.1 and 2.2. Briefly, AEX beads of different 
sizes were challenged with bacteriophage and influzenza B virus feed streams and the amount of virus in 
the flow-through from these columns was detected. As seen in Figure 2 (a) & (b) no virus bound to the 
uncharged 90 µm beads resulting in a large total bacteriophage recovery and complete recovery of 
influenza virus. However the 90 µm AEX beads bound significantly higher number of bacteriophage 
resulting in a lower total virus recovery than the 200 µm beads by one log. Similarly in the case of  
influenza virus feed stream, increasing the bead size from 34 to 200 µm drastically improved the virus 
recovery from 1.5 to 56%. The above observations confirm the theory that reducing the external surface 
area per unit volume of a resin column by increasing the bead size improves virus recovery in a flow-
through mode.  Further, as the above studies showed similar results in buffer and crude cell culture 
medium it indicates that the virus recovery using this technique is independent of the mobile phase. 
 
3.1.3. Flow-Through Column Purification of Influenza A Virus 
 
While the results in section 3.1.1 provided evidence of improvement in virus recovery using this 
approach, further studies were performed as described in section 2.3 using an impure feed stream of 
influenza A virus and columns containing 200µm beads with different chemistries to determine if 
sufficient impurity removal could be achieved using this technique. A 0.8 ml column containing 90 µm 
AEX beads was used as the control and three columns containing (1) 0.8 ml of 200 µm AEX beads, (2) 
50:50 v/v (1.6 ml) mixture of 200 µm AEX and HIC beads (2) 33:33:33 v/v (2.4ml) mixture of 200 µm 
AEX, CEX and HIC beads, were tested for HCP removal as well as virus recovery. Figure 3 (b) shows 
that all three column prototypes with 200 µm beads had higher virus recovery than the 90 µm AEX 
control column. With addition of HIC and CEX beads to the column the HCP removal by 200 µm 
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prototypes increased and exceeded that of the control 90 µm AEX column. In addition, despite the 
increase in column volume due to addition of HIC and CEX beads the virus recovery did not suffer 
appreciably. This can be attributed to the absence of interactions between these beads and the virus under 
the buffer conditions used in this study. This high recovery coupled with high impurity removal 
significantly increased the purity of the product obtained from the 200 µm columns relative to 90 µm 
AEX column by up to 44% as seen in the Table 1.  The above study demonstrates that flow through 
column chromatography can be used as an effective technique to separate viruses from HCP for viral 
vaccine purification. 
 
 
Figure 3: (a) Typical breakthrough curve for influenza virus and HCP through 0.8 ml 90 and 200µm AEX bead 
columns (b) % influenza virus recovery and % HCP removal using 200µm beads with different chemistries 
 
Table 1: Improvement in virus purity with change in bead chemistries relative to 90 µm AEX column 
 
%Improved purity = (ratio of the host cell protein to virus in control- ratio of the host cell protein to virus in prototype)/ ratio of the 
host cell protein to virus in control 
3.2. Flow thorough membrane chromatography for host cell DNA removal 
Previously flow-through separation of virus from whole DNA using AEX media containing quaternary 
amine chemistry has been reported with little success [9]. However, there have been no successful reports 
of use of AEX media with primary amine chemistry for this separation. Primary amine membranes have 
been shown to have very high DNA binding capacity in other applications such as mAb purification 
[3,10]. But the buffer conditions typically used in these applications also promote significant amount of 
virus binding to the primary amine media [3,10]. Hence in this study an innovative combination of buffer 
conditions were developed which allows selective binding of whole DNA to a primary amine media while 
allowing most of the virus to flow-through.  
 
Flow-through purification of influenza A virus through a commercially available primary amine 
membrane (ChromaSorbTM) was evaluated using a combination of multivalent ions and sodium chloride 
in the mobile phase buffer as described in section 2.4. For this test buffers containing multivalent ions 
Column type 90 µm AEX beads 200 µm AEX beads 200 µm AEX-HIC 
beads 
200 µm AEX-CEX-
HIC beads 
% Improved purity 1 15 26 44 
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such as phosphate and citrate were either prepared individually or used as additives in Tris buffer. Tris 
buffer without any multivalent ions or sodium chloride was used as the control. Figure 4(a) shows a 
typical break-through curve for virus and DNA through the ChromaSorb membrane in the presence of 
citrate ions and sodium chloride at 50mM and 0.3M NaCl concentration respectively. It can be observed 
that the virus instantly broke through indicating minimal binding to the primary amine matrix in the 
presence of multivalent ions, whereas the hcDNA had a significantly delayed break-through suggesting 
no significant hindrance for DNA binding. The above observation was confirmed in various buffers 
shown in Figure 4 (b). As seen the virus recovery was negligible in Tris buffer. However in phosphate 
buffer or with the addition of phosphate or citrate ions to Tris buffer the virus could be completely 
recovered. At the same time the DNA content in the flow-through pool was reduced to <10 ng  (indicated 
as 100% removal in Figure 4(b)) irrespective of the absence or presence of multivalent ions in the buffer 
for the column volumes of feed processed.  
 
  
Figure 4: (a) Typical break through curve for influenza virus type A /WS/N1H1 and hcDNA obtained by passing a 
feed in 50mM Tris buffer with 50mM citrate and 0.3M NaCl (pH 8) through a 0.08 ml primary amine membrane 
device (ChromaSorb). (b) Total virus recovery and DNA removal calculated at a throughput of 187CV of influenza 
feed processed through the membrane in respective buffers. Feed hc DNA and virus concentrations were similar to 
that shown in Figure 4 (a). 100% DNA removal corresponds to <10ng of DNA product pool. 
 
The results of the study indicate that the in the presence of multivalent ions the nature of the 
interactions between primary amine groups and the virus is significantly altered, while that with DNA 
molecules are mostly conserved. This change in behavior by the primary amine groups and bio-molecules 
is not fully understood and is under further investigation. Similar behavior can be expected using resins 
containing primary amine groups. However as the size of whole DNA is similar to that of viruses it can 
bind only to the external surface area of the beads leading to lower DNA capacity than a membrane 
adsorber.  
  
4. Conclusions 
The above study shows that improved virus recovery can be achieved in a flow-through mode by 
minimizing external surface area per unit volume of a resin column which when combined with optimum 
bead chemistry can provide good HCP removal. Also primary amine membranes can be used for flow-
through separation of hcDNA from viruses in presence of multivalent ions in the process buffer. The use 
of such a membrane might eliminate the need for addition of nucleases to virus harvests to break down 
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hcDNA, thereby creating a cleaner and less expensive process. Further, since only unbound and 
unconcentrated virus in recovered in the above two flow-through techniques, it minimizes the risk of loss 
of viability or chances of aggregation of the virus. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Proposed two step continuous process for flow-through purification of influenza virus 
The above two techniques can be potentially combined into a sequential two-step flow-through process 
to allow continuous purification of virus feed streams. As shown in Figure 5 a big bead column can be 
used as the first step to remove HCP followed by a primary amine membrane to remove hcDNA when 
accompanied by in-line mixing of multivalent ions into the flow-through between the two steps. Such a 
process may minimize the volume of buffers used as compared to a typical bind and elute 
chromatography process. However unlike centrifugation or bind and elute chromatography the above 
flow-through process cannot concentrate the virus. This may be disadvantageous or advantageous 
depending on the application. Since the above two flow-through techniques are not limited by the nature 
of the virus being purified and also compliment each other in terms of impurity removal, the two step 
process can be easily extended to purification of a wide variety of viruses with some optimization. 
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